Literature DB >> 9196217

Monoclonal antibodies capable of distinguishing epizootic from enzootic varieties of subtype 1 Venezuelan equine encephalitis viruses in a rapid indirect immunofluorescence assay.

J T Roehrig1, R A Bolin.   

Abstract

We used previously characterized murine monoclonal antibodies to develop a panel useful in subtyping Venezuelan equine encephalitis (VEE) viruses by an indirect fluorescent antibody assay. This panel worked well with either prototype VEE viruses or a series of more recent VEE virus isolates. The panel is particularly useful for rapidly differentiating VEE viruses with epidemic-epizootic potential from other endemic varieties of this virus. Using this panel, we identified an antigenic variant of prototype VEE subtype 1E virus currently present in Mexico. This antigenic change in the E2 glycoprotein was confirmed by enzyme-linked immunosorbent assay. Because VEE virus virulence has been associated in part with the E2 glycoprotein, this observed antigenic change in the 1E virus E2 glycoprotein may explain the apparent equine virulence of this unusual VEE 1E virus.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9196217      PMCID: PMC229865          DOI: 10.1128/jcm.35.7.1887-1890.1997

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  14 in total

1.  Use of a new synthetic-peptide-derived monoclonal antibody to differentiate between vaccine and wild-type Venezuelan equine encephalomyelitis viruses.

Authors:  J T Roehrig; R A Bolin; A R Hunt; T M Woodward
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

2.  Identification of monoclonal antibodies capable of differentiating antigenic varieties of eastern equine encephalitis viruses.

Authors:  J T Roehrig; A R Hunt; G J Chang; B Sheik; R A Bolin; T F Tsai; D W Trent
Journal:  Am J Trop Med Hyg       Date:  1990-04       Impact factor: 2.345

3.  Monoclonal antibodies define antigenic variation in the ID variety of Venezuelan equine encephalitis virus.

Authors:  R Rico-Hesse; J T Roehrig; R W Dickerman
Journal:  Am J Trop Med Hyg       Date:  1988-01       Impact factor: 2.345

4.  Antigenic analysis of the surface glycoproteins of a Venezuelan equine encephalomyelitis virus (TC-83) using monoclonal antibodies.

Authors:  J T Roehrig; J W Day; R M Kinney
Journal:  Virology       Date:  1982-04-30       Impact factor: 3.616

5.  Variants of Venezuelan equine encephalitis virus that resist neutralization define a domain of the E2 glycoprotein.

Authors:  B J Johnson; J R Brubaker; J T Roehrig; D W Trent
Journal:  Virology       Date:  1990-08       Impact factor: 3.616

6.  Molecular evidence for the origin of the widespread Venezuelan equine encephalitis epizootic of 1969 to 1972.

Authors:  R M Kinney; K R Tsuchiya; J M Sneider; D W Trent
Journal:  J Gen Virol       Date:  1992-12       Impact factor: 3.891

7.  Molecular evidence that epizootic Venezuelan equine encephalitis (VEE) I-AB viruses are not evolutionary derivatives of enzootic VEE subtype I-E or II viruses.

Authors:  J M Sneider; R M Kinney; K R Tsuchiya; D W Trent
Journal:  J Gen Virol       Date:  1993-03       Impact factor: 3.891

8.  Genetic evidence that epizootic Venezuelan equine encephalitis (VEE) viruses may have evolved from enzootic VEE subtype I-D virus.

Authors:  R M Kinney; K R Tsuchiya; J M Sneider; D W Trent
Journal:  Virology       Date:  1992-12       Impact factor: 3.616

9.  Phylogenetic analysis of alphaviruses in the Venezuelan equine encephalitis complex and identification of the source of epizootic viruses.

Authors:  S C Weaver; L A Bellew; R Rico-Hesse
Journal:  Virology       Date:  1992-11       Impact factor: 3.616

10.  Emergence of a new epidemic/epizootic Venezuelan equine encephalitis virus in South America.

Authors:  R Rico-Hesse; S C Weaver; J de Siger; G Medina; R A Salas
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

View more
  21 in total

1.  Potential sources of the 1995 Venezuelan equine encephalitis subtype IC epidemic.

Authors:  A C Brault; A M Powers; G Medina; E Wang; W Kang; R A Salas; J De Siger; S C Weaver
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

2.  Development of human-murine chimeric immunoglobulin G for use in the serological detection of human flavivirus and alphavirus antibodies.

Authors:  Brett A Thibodeaux; Amanda N Panella; John T Roehrig
Journal:  Clin Vaccine Immunol       Date:  2010-08-25

3.  Genetic and phenotypic changes accompanying the emergence of epizootic subtype IC Venezuelan equine encephalitis viruses from an enzootic subtype ID progenitor.

Authors:  E Wang; R Barrera; J Boshell; C Ferro; J E Freier; J C Navarro; R Salas; C Vasquez; S C Weaver
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

4.  Liposome-antigen-nucleic acid complexes protect mice from lethal challenge with western and eastern equine encephalitis viruses.

Authors:  Aaron T Phillips; Tony Schountz; Ann M Toth; Amber B Rico; Donald L Jarvis; Ann M Powers; Ken E Olson
Journal:  J Virol       Date:  2013-11-20       Impact factor: 5.103

Review 5.  Alphaviruses: population genetics and determinants of emergence.

Authors:  Scott C Weaver; Richard Winegar; Ian D Manger; Naomi L Forrester
Journal:  Antiviral Res       Date:  2012-04-19       Impact factor: 5.970

6.  CD4+ T cells provide protection against acute lethal encephalitis caused by Venezuelan equine encephalitis virus.

Authors:  Nadezhda E Yun; Bi-Hung Peng; Andrea S Bertke; Viktoriya Borisevich; Jennifer K Smith; Jeanon N Smith; Allison L Poussard; Milagros Salazar; Barbara M Judy; Michele A Zacks; D Mark Estes; Slobodan Paessler
Journal:  Vaccine       Date:  2009-05-03       Impact factor: 3.641

7.  Generation and characterization of closely related epizootic and enzootic infectious cDNA clones for studying interferon sensitivity and emergence mechanisms of Venezuelan equine encephalitis virus.

Authors:  Michael Anishchenko; Slobodan Paessler; Ivorlyne P Greene; Patricia V Aguilar; Anne-Sophie Carrara; Scott C Weaver
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

8.  Venezuelan encephalitis emergence mediated by a phylogenetically predicted viral mutation.

Authors:  Michael Anishchenko; Richard A Bowen; Slobodan Paessler; Laura Austgen; Ivorlyne P Greene; Scott C Weaver
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-20       Impact factor: 11.205

9.  Resistance to alpha/beta interferons correlates with the epizootic and virulence potential of Venezuelan equine encephalitis viruses and is determined by the 5' noncoding region and glycoproteins.

Authors:  D R Spotts; R M Reich; M A Kalkhan; R M Kinney; J T Roehrig
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

10.  Natural enzootic vectors of Venezuelan equine encephalitis virus, Magdalena Valley, Colombia.

Authors:  Cristina Ferro; Jorge Boshell; Abelardo C Moncayo; Marta Gonzalez; Marta L Ahumada; Wenli Kang; Scott C Weaver
Journal:  Emerg Infect Dis       Date:  2003-01       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.